Latest News for: Novo Nordisk

Edit

NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit

PR Newswire 10 Aug 2025
Notably, Novo Nordisk's asserted potential to capitalize on the compounded market greatly understated the potential impact of the personalization exception to the compounded GLP-1 exclusion and ...
Edit

Deadline Approaching: Novo Nordisk A/S (NVO) Investors Who Lost Money Urged To Contact Law Offices ...

Business Wire 09 Aug 2025
... filed on behalf of investors who purchased Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE.
Edit

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons (Novo Nordisk A/S)

Public Technologies 08 Aug 2025
2025-08-08 15.15.45 CEST Novo Nordisk A/S - Managers' Transactions Novo Nordisk A/S. Trading in Novo Nordisk shares by board members, executives and associated persons ... a) Name Novo Nordisk A/S ... Identification code Novo Nordisk B DK0062498333.
Edit

Trading in Novo Nordisk shares by board members, executives and associated persons (Form 6-K) (Novo Nordisk A/S)

Public Technologies 08 Aug 2025
... to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons.
Edit

TRC Announces Termination of the Tender Offer for Novo Nordisk A/S

Hastings Tribune 08 Aug 2025
... Depositary Shares (the “Shares”) of Novo Nordisk A/S.
Edit

The rise, fall and rise again of Novo Nordisk shares

CNBC 08 Aug 2025
CNBC's Silvia Amaro takes a look at the rise and fall in Novo Nordisk shares ... .
Edit

How Ozempic Maker Novo Nordisk Lost Its Shine

New York Times 08 Aug 2025
The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes ... .
Edit

Investors who lost money on Novo Nordisk A/S(NVO) should contact Levi & Korsinsky about pending ...

Nasdaq Globe Newswire 08 Aug 2025
NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S ("Novo" or the "Company") (NYSE. NVO) of a class action securities lawsuit ... .
×